Rigenase® and Polyhexanide combination for Wounds Treatment: The PMCF Survey

As the sequence of events of impaired wound healing is well characterized, the possibility to identify treatments that are already in the market and that are known to target one or, even better, many of the described molecular events can be taken into account. In this regard, several molecules with different indications have shown beneficial effects in promoting wound healing. Through these molecules, a most recent and effective one is represented by Rigenase®, a peculiar patented triticum vulgare extract which in association with polyhexanide, an antiseptic that doesn’t give any resistance to bacteria, characterizes the Fitostimoline® Plus formulations. Rigenase®, consists of a mix of oligosaccharides, having consolidated activities in the wound healing process. Polyhexanide is an antiseptic that has specific activities on bacteria, fungi and some viruses. The Fitostimoline®Plus formulations are present in the form of gauzes, spray and cream and all represent a valid and safe alternative for the treatment of various type of wounds, including burns, abrasions, ulcers and lesions. In this trial, we evaluated through a survey on a large population of patients, the efficacy and tolerability of the Fitostimoline® Plus formulations considering which one is the eligible product for each specific indication, in order to help the physicians to choose among the various types of these medical devices